Michitaka Imai Selected Research

Michitaka Imai Research Topics

Disease

38	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 11/2007
10	Neoplasms (Cancer) 01/2022 - 11/2007
5	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2009
5	Liver Neoplasms (Liver Cancer) 08/2021 - 01/2019
4	Ascites 05/2022 - 04/2021
3	Fatigue 06/2022 - 01/2022
3	Hepatic Encephalopathy 06/2022 - 01/2017
3	Hemorrhage 04/2022 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 04/2022 - 11/2012
3	Thrombosis (Thrombus) 02/2021 - 11/2007
2	Carcinoma (Carcinomatosis) 09/2022 - 02/2018
2	Hypertension (High Blood Pressure) 03/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 02/2018
2	Chronic Hepatitis C 03/2021 - 10/2018
2	Liver Diseases (Liver Disease) 01/2021 - 05/2019
1	Hypothyroidism 06/2022
1	Diarrhea 06/2022
1	Edema (Dropsy) 05/2022
1	Sarcopenia 07/2021
1	Disease Progression 07/2021
1	Infections 03/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Alcoholic Fatty Liver 01/2021
1	Hyperammonemia 01/2020
1	Thrombocytopenia (Thrombopenia) 05/2019
1	Fistula 12/2018
1	Eosinophilia 01/2018
1	Cholangiocarcinoma 01/2018
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2017
1	Alcoholic Hepatitis 02/2014
1	Inflammation (Inflammations) 02/2014
1	Leukocytosis (Pleocytosis) 02/2014
1	Persistent Infection 02/2013
1	Immunoglobulin G4-Related Disease 01/2013
1	Fibrosis (Cirrhosis) 11/2012
1	Pancreatitis 03/2009

Drug/Important Bio-Agent (IBA)

22	lenvatinibIBA 06/2022 - 01/2019
9	AlbuminsIBA 01/2022 - 01/2019
8	atezolizumabIBA 10/2022 - 01/2022
8	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2022
8	BilirubinIBA 01/2022 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2009
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022 - 04/2021
4	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 01/2017
3	C-Reactive ProteinIBA 10/2022 - 01/2022
2	acarboxyprothrombin (PIVKA)IBA 01/2022 - 04/2009
2	Serum AlbuminIBA 01/2022 - 08/2021
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 04/2009
2	regorafenibIBA 08/2021 - 01/2019
2	SofosbuvirIBA 03/2021 - 10/2018
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2019
2	UracilIBA 04/2009 - 11/2007
2	TegafurIBA 04/2009 - 11/2007
1	Urea (Carbamide)FDA LinkGeneric 05/2022
1	Tolvaptan FDA Link 12/2021
1	RamucirumabIBA 04/2021
1	ledipasvirIBA 03/2021
1	Fetal Proteins (Fetoprotein)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Rifaximin (L 105)FDA Link 01/2020
1	lusutrombopagIBA 05/2019
1	Thrombopoietin ReceptorsIBA 05/2019
1	Antiviral Agents (Antivirals)IBA 10/2018
1	Ritonavir (Norvir)FDA Link 10/2018
1	ombitasvirIBA 10/2018
1	paritaprevirIBA 10/2018
1	Ribavirin (Virazole)FDA LinkGeneric 10/2018
1	Proton Pump InhibitorsIBA 01/2018
1	edoxabanIBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 10/2017
1	telomerase RNA (bTR)IBA 10/2017
1	Branched-Chain Amino AcidsIBA 10/2017
1	miriplatinIBA 01/2017
1	CytokinesIBA 02/2014
1	Interleukin-8 (Interleukin 8)IBA 02/2014
1	Immunoglobulin G (IgG)IBA 01/2013
1	Prednisolone (Predate)FDA LinkGeneric 01/2013
1	Biomarkers (Surrogate Marker)IBA 11/2012
1	Keratins (Keratin)IBA 11/2012
1	Vitamin K FDA Link 04/2009
1	Docetaxel (Taxotere)FDA Link 04/2009
1	Cisplatin (Platino)FDA LinkGeneric 04/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2009
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2009
1	Fluorouracil (Carac)FDA LinkGeneric 11/2007

Therapy/Procedure

16	Therapeutics 06/2022 - 04/2009
5	Drug Therapy (Chemotherapy) 01/2020 - 11/2007
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 06/2022 - 01/2020
2	Self Expandable Metallic Stents 08/2021 - 02/2018
2	Radiofrequency Ablation 05/2019 - 07/2017
2	Catheters 12/2018 - 01/2016
1	Immunotherapy 10/2022
1	Stents 08/2021
1	Retreatment 10/2018
1	Operative Surgical Procedures 02/2018
1	Sclerotherapy 01/2017
1	Hepatectomy 04/2009
1	Combination Drug Therapy (Combination Chemotherapy) 11/2007